Companies Dominating the Prednisone Market
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- GSK plc
- Sanofi
- AstraZeneca
- Eli Lilly and Company
- AbbVie Inc.
- Bristol Myers Squibb Company
- F. Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of prednisone is assessed at USD 6.6 billion.
The prednisone market size was over USD 6.32 billion in 2024 and is projected to reach USD 12.37 billion by 2037, growing at around 5.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in covid-19 cases, rise in prevalence of irritable bowel, and growth in geriatric population.
North America industry is estimated to hold largest revenue share of 35% by 2037, due to rising prevalence of asthma in the region.
The major players in the market are Pfizer Inc., Merck & Co., Inc., GSK plc, Sanofi, and others.
